FMRI shows dysfunction in bipolar, ADHD patients
University of Illinois at Chicago researchers using functional MRI found the dorsolateral prefrontal cortex region of the brain is less active in patients with pediatric bipolar disorder and attention deficit hyperactivity disorder than in controls.
University of Illinois at Chicago researchers using functional MRI found the dorsolateral prefrontal cortex region of the brain is less active in patients with pediatric bipolar disorder and attention deficit hyperactivity disorder than in controls. The prefrontal cortex controls behavior such as impulsivity, executive function, and cognitive processes such as working memory, attention, and language.
The researchers imaged children aged 10 to 18 with fMRI as they performed a working memory task. Subjects with bipolar disorder exhibited greater deployment of the emotion-processing circuitry and reduced deployment of working memory circuitry compared with healthy subjects. Commonalities with attention deficit hyperactivity disorder included corticosubcortical activity that was reduced under negative emotional challenge and increased under positive emotional challenge (J Am Acad Child Adolesc Psychiatry 2010;49:1064-1080).
The goal of the research is to develop imaging markers of behavioral illness that can be used in a clinical setting, the authors said.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
